Charles Schwab’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Charles Schwab’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-18,686	Closed	-$791K	–	3707
2024 Q1	$791K	Hold	18,686	–	–	﹤0.01%	2860
2023 Q4	$781K	Sell	18,686 -8	-0%	-$334	﹤0.01%	2915
2023 Q3	$705K	Hold	18,694	–	–	﹤0.01%	2919
2023 Q2	$709K	Buy	+18,694	New	+$709K	﹤0.01%	2893
2021 Q1	–	Sell	-38,541	Closed	-$2.83M	–	3524
2020 Q4	$2.83M	Buy	38,541 +1,943	+5%	+$143K	﹤0.01%	2483
2020 Q3	$2.01M	Sell	36,598 -568	-2%	-$31.2K	﹤0.01%	2489
2020 Q2	$2.47M	Sell	37,166 -9,142	-20%	-$608K	﹤0.01%	2345
2020 Q1	$2.84M	Buy	46,308 +7,530	+19%	+$461K	﹤0.01%	2117
2019 Q4	$3.41M	Buy	38,778 +1,544	+4%	+$136K	﹤0.01%	2216
2019 Q3	$2.81M	Buy	37,234 +3,290	+10%	+$248K	﹤0.01%	2256
2019 Q2	$2.9M	Sell	33,944 -103	-0.3%	-$8.8K	﹤0.01%	2225
2019 Q1	$3.68M	Buy	34,047 +23,330	+218%	+$2.52M	﹤0.01%	2126
2018 Q4	$908K	Buy	10,717 +487	+5%	+$41.3K	﹤0.01%	2565
2018 Q3	$1.01M	Buy	10,230 +204	+2%	+$20.1K	﹤0.01%	2620
2018 Q2	$1.16M	Buy	10,026 +2,054	+26%	+$238K	﹤0.01%	2545
2018 Q1	$788K	Buy	7,972 +2,470	+45%	+$244K	﹤0.01%	2594
2017 Q4	$577K	Sell	5,502 -1,012	-16%	-$106K	﹤0.01%	2690
2017 Q3	$735K	Buy	6,514 +1,664	+34%	+$188K	﹤0.01%	2598
2017 Q2	$544K	Buy	4,850 +1,306	+37%	+$146K	﹤0.01%	2661
2017 Q1	$414K	Hold	3,544	–	–	﹤0.01%	2710
2016 Q4	$374K	Sell	3,544 -32,400	-90%	-$3.42M	﹤0.01%	2759
2016 Q3	$3.97M	Sell	35,944 -20,000	-36%	-$2.21M	﹤0.01%	1798
2016 Q2	$8.15M	Buy	55,944 +53,984	+2,754%	+$7.86M	0.01%	1215
2016 Q1	$281K	Hold	1,960	–	–	﹤0.01%	2795
2015 Q4	$303K	Buy	+1,960	New	+$303K	﹤0.01%	2857
2015 Q1	–	Sell	-5,988	Closed	-$888K	–	3088
2014 Q4	$888K	Hold	5,988	–	–	﹤0.01%	2409
2014 Q3	$922K	Sell	5,988 -4,000	-40%	-$616K	﹤0.01%	2336
2014 Q2	$1.4M	Buy	9,988 +3,900	+64%	+$547K	﹤0.01%	2175
2014 Q1	$676K	Buy	+6,088	New	+$676K	﹤0.01%	2470